EP Patent

EP0092999A2 — Dressing

Assigned to ER Squibb and Sons LLC · Expires 1983-11-02 · 43y expired

What this patent protects

This invention is directed to an occlusive dressing useful for treating skin lesions and a granular material' capable of interacting with wound exudate. Wounds emitting a large amount of fluid can be treated by first packing with the granular material and then covering the wound …

USPTO Abstract

This invention is directed to an occlusive dressing useful for treating skin lesions and a granular material' capable of interacting with wound exudate. Wounds emitting a large amount of fluid can be treated by first packing with the granular material and then covering the wound with the occlusive dressing.

Drugs covered by this patent

Patent Metadata

Patent number
EP0092999A2
Jurisdiction
EP
Classification
Expires
1983-11-02
Drug substance claim
No
Drug product claim
No
Assignee
ER Squibb and Sons LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.